- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: Americans Skeptical About Patient-Centered Care Benefits
What we're reading, November 9, 2015: Americans worry patient-centered care is a gimmick; insurers raise new concerns over the increasing prices for generic drugs; and President Obama challenges 20 cities to sign up the most uninsured on the exchanges.
Skepticism Remains Barrier to Patient-Centered Care
An article by the Associated Press (AP) is highlighting the benefits of patient-centered care as the culture of America’s health system change from treating symptoms to treating people. The biggest hurdle to overcome remains getting people to buy into the concept: an AP poll found that there is skepticism among Americans age 40 years and older who have not tried this type of care. However, people who have experienced an aspect of patient-centered care have felt the improvement in care.
New Concerns Over the Increasing Prices for Generic Drugs
While most of the concerns regarding soaring drug prices have focused on new specialty treatments, insurers are now seeing huge increases for some commonly used drugs, according to the Boston Globe. While the increases appear modest—one antibiotic climbed 6 cents—the costs can add up quickly because these drugs are used in high volumes.
Obama Administration Challenges Cities to Get the Most People Signed Up for Insurance
President Obama is challenging cities to compete and sign up the most people during the third year of open enrollment on the Affordable Care Act’s health insurance exchanges. The Healthy Communities Challenge is targeting the 20 cities with the most uninsured people eligible for marketplace coverage and the city with the most sign-ups will get a presidential visit.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
